Stem Cell Replacement Therapy: Its Time has Begun
ViaCyte has results on its second stem cell-based technology, providing evidence of stem cells secreting insulin in response to meal consumption.
Progress Toward Cures: Thoughts at Year’s End from Breakthrough T1D’s CEO
Breakthrough T1D CEO Aaron Kowalski, Ph.D., weighs in on the exciting news surrounding stem cell-derived beta cell replacement therapies, now in human clinical trials.
Find Your Something
A resident physician and T1D dad—who also lives with an autoimmune disease—shares his call to action to support Breakthrough T1D and research to cure T1D and improve lives.
First-in-Human Gene-Edited Stem Cell Trial? Check.
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, and CRISPR Therapeutics have a new first: Gene-editing for type 1 diabetes.
First-in-Human T1D Vaccine Trial Reports Positive Results
A first-in-human study of the coxsackie B vaccine—made by Breakthrough T1D-funded researchers Drs. Hyoty and Knip—reports positive results.
Artificial pancreas systems: Sleeping without fear
Research shows Artificial Pancreas Systems can help improve diabetes-related outcomes and lighten the burden of T1D. Even during sleep.
Smart Insulin Pen/Smart Cap Bridge Technology Gap for MDI
People living with T1D who prefer multiple daily injections (MDI) of insulin now have two high-tech management options: An insulin smart pen or an insulin smart pen cap.
Vertex Shares Data from Their Stem Cell-Derived Therapy—and It’s Outstanding
In February, Vertex announced they were beginning a clinical trial for VX-880, their stem cell-derived therapy for use in people with type 1 diabetes (T1D). Today, they announced that the first person to receive this therapy now needs 91% less insulin 90 days after receiving an infusion of these fully differentiated cells at just half […]
Breakthrough T1D Mourns the Loss of Stacey Anderson, M.D.
Breakthrough T1D is deeply saddened at the passing of Stacey Anderson, M.D. Dr. Anderson was a tireless champion for the type 1 diabetes (T1D) community, a brilliant researcher, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, and friend. “Dr. Stacey Anderson was a tremendous diabetes champion and she will be terribly missed,” said Breakthrough […]
EASD Conference Will Bring Together—Virtually—Top Minds in Diabetes Research
Leading researchers from around the world will gather for the annual meeting of the European Association for the Study of Diabetes (EASD).
